Immunology
Immune Relationship to Lung Tumor Evolution Characterized
Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC). NSCLC accounts for about 85% of all lung cancers. As a class, NSCLCs are relatively insensitive to chemotherapy, compared to small cell carcinoma. More...04 Apr 2019

Preterm Birth Clues Identified in Cervicovaginal Microbiome
Failure to predict and understand the causes of preterm birth, the leading cause of neonatal morbidity and mortality, have limited effective interventions and therapeutics. Preterm birth (PTB) is defined as birth before 37 completed weeks of gestation and is the leading cause of death in neonates and children under the age of 5. More...03 Apr 2019

Blood Test to Diagnose Heart Attacks Can Be Misleading
The use of increasingly sensitive troponin assays for excluding or diagnosing acute myocardial infarction has become universal. A diagnosis of acute myocardial infarction is defined, in the context of an appropriate clinical presentation, by a rise or fall in cardiac troponin concentration, now the gold standard biomarker. More...27 Mar 2019

Oral Bacteria Linked to More Aggressive Tumors
Pancreatic cystic neoplasms (PCN) are increasingly detected in the general population. They comprise a clinically challenging entity with potential to progress to invasive cancer. The disease is often discovered late, which means that in most cases the prognosis is poor. More...26 Mar 2019

Urinary KIM-1 Concentration Interpreted in Detecting AKI
Kidney injury molecule-1 (KIM-1) has been identified as a biomarker for the assessment of nephropathy in various chronic kidney diseases (CKD). Extensive KIM-1 expression occurs in proximal tubule cells in patients with confirmed acute tubular necrosis. More...25 Mar 2019

Efficacy Investigated for Electrochemiluminescence Immunoassay
Syphilis caused by Treponema pallidum is a chronic bacterial infection. T. pallidum cannot be cultured in vitro, and new molecular tests for syphilis are unlikely to replace serology in the short term because they are fairly expensive and require sophisticated equipment. More...20 Mar 2019

Recurrent Miscarriage Patients Show Activated Immune System
Recurrent loss of pregnancy is an important reproductive health issue, affecting 2% to 5% of couples. Almost half of the cases remain unexplained and are treated empirically, using progesterone supplementation, anticoagulation, and/or immunomodulatory approaches. More...19 Mar 2019
In Other News
Fecal Immunochemical Tests Performance Characterized for CRC
Immunohistochemical Stain Facilitates cHL Diagnosis
Cervical Microbes Potentially Tied to Infections and Lesions
Lateral Flow RPA Assay Developed for Cryptococcus in CSF
Intestinal Mucosa Fungus Can Affect Lung Health
Atrophic Gastritis Prevalence Determined by Serological Evidence
Accuracy of Self-Sampling for HPV Screening Evaluated
Genetic Causes of Salivary Gland Carcinoma Discovered
Blood Test Detects Brain Damage Years before Symptoms
Unique Form of Chronic Sinusitis Diagnosed in Older Patients
Diagnostic Methods for Infectious Uveitis Investigated
New Blood Tests for TB Could Accelerate Diagnosis
Blood Test Diagnoses Pancreatic Cancer Disease Earlier
Bench-Top Immunoanalyzer Evaluated for βhCG Assay
Unconventional Cells Trigger Cytokine Production in Spondyloarthritis
CD69 Biomarker Expression Predicts Atherosclerosis Risk
Rapid Diagnostic Tests Evaluated for HIV/Syphilis
Persistent Fatigue Induced by Interferon-Alpha
Genetic Mutation Identified for TB Vulnerability
Calprotectin Independently Predicts Relapse in Treated RA
Urinary Biomarkers Associated with Kidney Disease Risk Factors
Dengue Virus IgM Serotyped by ELISA
Genetic and Epigenetic Features Found in Glioma Tumors
The Immunology channel of LabMedica deals with diagnostic techniques and immuonassays such as ELISA, pregnancy tests, immunoblotting, immunohistochemical staining, serology, and associated hardware.







